I.M.D. International Medical Devices S.p.A. (BIT:IMD)
1.260
+0.030 (2.44%)
Last updated: Jul 21, 2026, 9:01 AM CET
BIT:IMD Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.35 | 8.34 | 4.55 | 3.01 | 6.74 |
Cash & Short-Term Investments | 8.35 | 8.34 | 4.55 | 3.01 | 6.74 |
Cash Growth | 0.18% | 83.24% | 51.38% | -55.38% | - |
Accounts Receivable | 7.28 | 8.05 | 8.52 | 9.3 | 9.14 |
Other Receivables | 2.23 | 2.48 | 4.96 | 2.36 | 2.06 |
Total Trade Receivables | 9.5 | 10.53 | 13.48 | 11.65 | 11.21 |
Inventory | 12.45 | 13.96 | 15.5 | 16.3 | 14.14 |
Total Current Assets | 30.31 | 32.83 | 33.53 | 30.96 | 32.08 |
Net Property, Plant & Equipment | 0.57 | 0.62 | 1.11 | 1.27 | 1.19 |
Other Intangible Assets | 1.21 | 1.29 | 1.26 | 0.14 | 0.07 |
Goodwill | 0.08 | 0.09 | - | 0.21 | 0.43 |
Long-Term Investments | 0.2 | 0.28 | 0 | 0 | 0 |
Other Long-Term Assets | 0.52 | 0.63 | 0.28 | 0.22 | 0.19 |
Total Assets | 32.89 | 35.74 | 36.19 | 32.8 | 33.96 |
Accounts Payable | 5.01 | 6.12 | 7.01 | 9.09 | 8.92 |
Accrued Expenses | 0.9 | 0.65 | 0.33 | 0.37 | 0.36 |
Short-Term Debt | 0.18 | 0.17 | 1.58 | 1.36 | 0.27 |
Current Portion of Long-Term Debt | - | - | - | - | 0.4 |
Unearned Revenue | 0.32 | 1.59 | 0.85 | 1.52 | 1.04 |
Other Current Liabilities | 1.72 | 1.87 | 1.64 | 1.85 | 2.32 |
Total Current Liabilities | 8.14 | 10.4 | 11.41 | 14.19 | 13.31 |
Long-Term Debt | 0.06 | 0.23 | 0 | 1.29 | 0.28 |
Other Long-Term Liabilities | 1.71 | 1.79 | 1.55 | 1.89 | 8.05 |
Total Long-Term Liabilities | 1.77 | 2.02 | 1.55 | 3.17 | 8.33 |
Total Liabilities | 9.91 | 12.42 | 12.96 | 17.36 | 21.64 |
Common Stock | 4 | 4 | 4 | 2.38 | 2.38 |
Treasury Stock | -0.1 | -0.1 | -0.1 | -0.52 | -0.52 |
Additional Paid-in Capital | 4.28 | 4.28 | 4.28 | 0.47 | 0.47 |
Accumulated Other Comprehensive Income | 0.58 | 0.58 | - | 0 | -0.02 |
Retained Earnings | 14.8 | 15.14 | 13.36 | 11.56 | 8.62 |
Total Common Shareholders' Equity | 22.98 | 23.31 | 21.54 | 13.9 | 10.96 |
Minority Interest | - | - | 3.38 | 3.08 | 2.74 |
Shareholders' Equity | 22.98 | 23.31 | 23.23 | 15.43 | 12.33 |
Total Liabilities & Equity | 32.89 | 35.74 | 36.19 | 32.8 | 33.96 |
Total Debt | 0.24 | 0.4 | 1.58 | 2.65 | 0.95 |
Net Cash (Debt) | 8.11 | 7.93 | 2.97 | 0.36 | 5.78 |
Net Cash Growth | 2.25% | 167.26% | 731.67% | -93.83% | - |
Net Cash Per Share | 0.47 | 0.46 | 0.27 | 0.01 | 0.14 |
Book Value | 22.98 | 23.31 | 21.54 | 13.9 | 10.96 |
Book Value Per Share | 1.33 | 1.35 | 1.94 | 0.47 | 0.27 |
Tangible Book Value | 21.69 | 21.94 | 20.28 | 13.55 | 10.46 |
Tangible Book Value Per Share | 1.25 | 1.27 | 1.83 | 0.46 | 0.25 |